欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3007/003
药品名称Ultrizor 40 mg/10 mg
活性成分
    • ezetimibe 10.0 mg
    • rosuvastatin zinc 40.0 mg
剂型Capsule, hard
上市许可持有人EGIS Pharmaceuticals PLC Keresztúri út 30-38 H-1106 Hungary
参考成员国 - 产品名称Netherlands (NL)
Ayadont 40 mg/10 mg harde capsule
互认成员国 - 产品名称
    • Latvia (LV)
      Rosulip 40 mg/10 mg cietās kapsulas
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
      VIAZET (ex DELIPID PLUS)
    • Poland (PL)
    • Estonia (EE)
      DELIPID PLUS
    • Bulgaria (BG)
      Rosulip Plus
许可日期2014/06/30
最近更新日期2024/07/28
药物ATC编码
    • C10BA06 rosuvastatin and ezetimibe
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase